Tirzepatide (Mounjaro®) in primary care for weight management

Tirzepatide (Mounjaro): prescribers must make sure patients are referred to a behavioural support service as part of wraparound care.

NHS England · Primary Care Bulletin item

Tirzepatide (Mounjaro®) in primary care for weight management

Published 27 August 2026 · Prescribing & medicines

← NHS England Primary Care Bulletin – 27 August 2026

NHSENews

In brief Tirzepatide (Mounjaro): prescribers must make sure patients are referred to a behavioural support service as part of wraparound care.

Read more at NHS England ↗

Read the full item in the bulletin ↗

From NHS England’s Primary Care Bulletin, issue 403, 27 August 2026. Headline is NHS England’s; summary by BLMC. The full bulletin is also published on patient.info.